Bill > S00748

This bill makes technical changes to existing public health law provisions regarding epinephrine auto-injector devices in places of public assembly. Specifically, the bill reletters an existing subdivision from 5-d to 5-e, updates cross-references to this subdivision, and modifies the effective date of the original law. The key changes include delaying the implementation of the original law from an immediate effect to nine months after becoming law, and allowing regulatory preparations to be made before the effective date. The bill appears to be a technical correction to previously proposed legislation (S. 1078-A and A. 2885-A) that required places of public assembly to have functional epinephrine auto-injectors and to have at least one trained employee or volunteer present during facility functions. An epinephrine auto-injector (commonly known by the brand name EpiPen) is a medical device used to treat severe allergic reactions. The bill ensures that the technical changes to the law are synchronized with the original legislation's implementation, providing clarity and a more structured approach to the requirement for epinephrine devices in public spaces.

https://www.nysenate.gov/legislation/bills/2025/S748